Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Prodrug activation using catalytic antibodies

Prodrug activation using catalytic antibodies

US Patent 6677435 · Granted Jan 13, 2004

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Chemiluminescent probes for diagnostics and in vivo imaging2025
Antibody compounds with reactive arginine and related antibody drug conjugates2025
Humanized anti-GDNF family alpha-receptor 4 (GRF-alpha-4) antibodies and chimeri2025
Chemiluminescent probes for imaging/detection of proteases2024
Articles and methods directed to personalized therapy of cancer2024
Treatment of cancer using GFR alpha-4 chimeric antigen receptor2024
Chemiluminescent probes for diagnostics and in vivo imaging2024
ROR2 antibody compositions and related methods2023
Humanized anti-GDNF family alpha-receptor 4 (GRF-alpha-4) antibodies and chimeri2023
Dioxetane compounds and their use for the detection of microorganisms2023
Chimeric polypeptides having targeted binding specificity2022
Antibody targeting cell surface deposited complement protein C3d and use thereof2022